Vanderbilt Pharmacogenetics

Overview

 

The investigators listed here are all involved in various Vanderbilt Pharmacogenetics Projects.

For their individual bios and information, please click on their respective names.

 

 

Dr. Richard Kim is a co-investigator working to understand mechanisms of drug interactions and toxicity.

His current research focus is to better understand the factors which determine interindividual variability in drug disposition. His lab currently studies drug transpoters and cytochrome P450 enzymes both at the molecular level and in humans.

Complete Information

 

 

 

;

 

Copyright©2004 Vanderbilt Pharmacogenetics/Vanderbilt University